Cordstem-ST(CHABiotech)(Cordstem-ST(CHABiotech)) - 在研适应症：原发性卵巢功能不全_专利_临床

概要

基本信息

药物类型

间充质干细胞疗法

别名

umbilical cord-derived mesenchymal stem cell(CHABiotech)

靶点-

作用方式-

作用机制

细胞替代物

治疗领域

内分泌与代谢疾病泌尿生殖系统疾病

在研适应症

原发性卵巢功能不全

非在研适应症

脑梗塞

原研机构

Cha Bio&Diostech Co. Ltd.

在研机构

Cha Bio&Diostech Co. Ltd.

非在研机构-

最高研发阶段临床1期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与 Cordstem-ST(CHABiotech) 相关的临床试验

NCT06578039

/ Recruiting临床1期

Single-dose, Phase 1 Clinical Trial to Evaluate the Safety, and Tolerability of Allogeneic Umbilical Cord-derived Mesenchymal Stem Cell Therapy in Patients With Premature Ovarian Insufficiency

This clinical study will evaluate the safety and tolerability of CordSTEM-ST after administering a single dose in patients with premature ovarian insufficiency (POI), as well as identify the maximum tolerated dose (MTD) and evaluate the potential therapeutic effects.

开始日期2024-08-01

申办/合作机构

Cha Bio&Diostech Co. Ltd.

NCT02378974

/ Completed临床1/2期

A Randomized, Double-blind, Placebo-controlled, Phase I/IIa Clinical Trial for Evaluation of Safety and Potential Therapeutic Effects After Intravenous Transplantation of Human Umbilical Cord-derived Mesenchymal Stem Cells in Patients With Cerebral Infarction Disease

The objective of the study is to evaluate the safety and the potential therapeutic effects per dose of Cordstem-ST Intravenous Transplantation in Cerebral Infarction subjects

开始日期2015-02-01

申办/合作机构

Cha Bio&Diostech Co. Ltd.

100 项与 Cordstem-ST(CHABiotech) 相关的临床结果

登录后查看更多信息

100 项与 Cordstem-ST(CHABiotech) 相关的转化医学

登录后查看更多信息

100 项与 Cordstem-ST(CHABiotech) 相关的专利（医药）

登录后查看更多信息

100 项与 Cordstem-ST(CHABiotech) 相关的药物交易

登录后查看更多信息